Recorded fact · drug.label_indication

drug.label_indication for alectinib-hcl|non-small-cell-lung-cancer

One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact ee93607c resolves to.

The record

Fact id	`ee93607ceef10b0a00b4ae75`
Entity	drug: alectinib-hcl\|non-small-cell-lung-cancer
Field	drug.label_indication
Source	api.fda.gov
Read on	2026-11-10T19:02:47.536Z
Source version	openfda-label-20260821
Method	extract
Verification	verified
Licence	CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels
Edition	2026-11, Merkle root `006ab9a329709cbe...`

The verifying quote

adjuvant treatment in adult patients following tumor resection of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (tumors ≥ 4 cm or node positive) as detected by an FDA-approved test.

Shown with dashes as hyphens. SHA-256 of the exact stored quote: e8129e3a8e99ab31343d7424dc994941c21ed8b48b903550d1ef6ddc5afc2d39.

The value

{
 "ingredient": "Alectinib HCl",
 "conditionId": "non-small-cell-lung-cancer",
 "conditionName": "Non-Small Cell Lung Cancer",
 "matchedAlias": "non-small cell lung cancer",
 "context": "indication",
 "brand": "ALECENSA",
 "identifiedVia": "generic_name",
 "extractor": 5,
 "labelSetId": "42c49deb-713b-427a-9670-08af08adcffb",
 "labelEffectiveTime": "20260821",
 "labelsRead": 1,
 "labelsNaming": 1,
 "registryEditionRoot": "1b44e76f5da1a417",
 "meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}

SHA-256 of the exact stored value: d01458159ef8c92c1296e7fc92e022d7f42dbabc27d46708b96d5b0229844b79.

This fact as data (JSON) · Check an answer against its receipt · Licence

Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.